The MATN1 antibody targets matrilin-1. a glycoprotein belonging to the matrilin family, which are extracellular matrix (ECM) proteins involved in tissue development and homeostasis. Matrilin-1. encoded by the *MATN1* gene, is primarily expressed in cartilage and plays a critical role in assembling and stabilizing the ECM through interactions with collagen fibrils and proteoglycans. It contains von Willebrand factor A (vWFA) domains and epidermal growth factor (EGF)-like repeats, structural motifs that mediate protein-protein interactions.
MATN1 antibodies are widely used in research to study cartilage biology, skeletal development, and diseases such as osteoarthritis or chondrodysplasias. These antibodies enable the detection and localization of matrilin-1 in tissues via techniques like immunohistochemistry, Western blotting, or immunofluorescence. Studies using MATN1 antibodies have revealed its involvement in ECM organization, cell adhesion, and signaling pathways regulating chondrocyte differentiation.
Altered matrilin-1 expression has been linked to cartilage degeneration, making it a potential biomarker for joint disorders. Additionally, MATN1 antibodies aid in characterizing genetically engineered mouse models to explore matrilin-1's functional roles. Despite its importance in cartilage, matrilin-1 is also found in non-skeletal tissues, suggesting broader physiological and pathological implications. Research utilizing MATN1 antibodies continues to uncover its molecular interactions and therapeutic relevance in connective tissue diseases.